Analyzing Cardiovascular Risks in Rheumatic Disease Drugs

This chapter examines the cardiovascular risks linked to rheumatic disease medications, focusing on tofacitinib and its related odds ratios for serious conditions like myocardial infarction and stroke. It emphasizes the often-neglected risks of prednisolone and presents research on the lasting cardiovascular effects of steroid use in rheumatoid arthritis patients.